GGrantIndex
← Leaderboards

Eugene P Orringer

University Of North Carolina Chapel Hill

Google Scholar ↗PubMed ↗ORCID ↗
$33,565,484
Attributed
$33,565,484
Total exposure
26
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $9.1M · FY2005–15
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$68,479,260 · 28

By mechanism

M01$41,712,338 · 20
K12$18,201,963 · 3
T32$6,966,562 · 1
C06$852,265 · 1
P20$438,000 · 2
U13$308,132 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research”

Research focus

Clinical ResearchHuman SubjectSickle Cell AnemiaHuman Therapy EvaluationDrug Screening /EvaluationBlood Disorder ChemotherapyClinical TrialsHydroxyureaErythrocytesAdult Human (21+)PainTraining ProgramsInterdisciplinary CollaborationHemoglobin FPharmacokineticsResearch PersonnelScientistFundingGrantMedicalUnited States National Institutes Of HealthMedical ComplicationAcute Disease /DisorderTraining

Grant awards (145)

Medical Scientist Training Program$759,204
T32 · FY2015 · GM · contact PI
Best Practices to Ensure Reproducibility and Rigor in Research$86,400
T32 · FY2015 · GM · contact PI
Medical Scientist Training Program$50,614
T32 · FY2015 · GM · contact PI
Medical Scientist Training Program$601,608
T32 · FY2014 · GM · contact PI
UNC BIRCWH Career Development Program$425,001
K12 · FY2014 · HD · contact PI
Medical Scientist Training Program$528,076
T32 · FY2013 · GM · contact PI
UNC BIRCWH Career Development Program$400,000
K12 · FY2013 · HD · contact PI
Medical Scientist Training Program$45,573
T32 · FY2013 · GM · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2012 · HD · contact PI
Medical Scientist Training Program$455,726
T32 · FY2012 · GM · contact PI
Medical Scientist Training Program$45,573
T32 · FY2012 · GM · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2011 · HD · contact PI
Medical Scientist Training Program$451,060
T32 · FY2011 · GM · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2010 · HD · contact PI
Medical Scientist Training Program$446,524
T32 · FY2010 · GM · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2009 · HD · contact PI
Medical Scientist Training Program$444,321
T32 · FY2009 · GM · contact PI
General Clinical Research Center$1,727,031
M01 · FY2008 · RR · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2008 · HD · contact PI
Medical Scientist Training Program$414,850
T32 · FY2008 · GM · contact PI
Medical Scientist Training Program$43,996
T32 · FY2008 · GM · contact PI
CLINICAL TRIAL: NEUROPSYCHOLOGICAL DYSFUNCTION AND NEUROIMAGING ABNORMALITIES IN$2,372
M01 · FY2008 · RR · contact PI
PERMEABILITY & METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$1,760
M01 · FY2008 · RR · contact PI
General Clinical ResearchCenter$5,116,206
M01 · FY2007 · RR · contact PI
Multidisciplinary Clinical Research Career Develop(RMI)$2,845,660
K12 · FY2007 · RR · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2007 · HD · contact PI
Medical Scientist Training Program$439,958
T32 · FY2007 · GM · contact PI
PERMEABILITY & METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$4,502
M01 · FY2007 · RR · contact PI
NEUROPSYCHOLOGICAL DYSFUNCTION AND NEUROIMAGING ABNORMALITIES IN SCD$2,626
M01 · FY2007 · RR · contact PI
SAFETY AND EFFICACY OF HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL$750
M01 · FY2007 · RR · contact PI
General Clinical ResearchCenter$5,115,540
M01 · FY2006 · RR · contact PI
Multidisciplinary Clinical Research Career Development$1,881,900
K12 · FY2006 · RR · contact PI
UNC-CH Mentored Clinical Research Scholar Program$668,634
K12 · FY2006 · RR · contact PI
UNC BIRCWH Career Development Program$500,000
K12 · FY2006 · HD · contact PI
Medical Scientist Training Program$439,958
T32 · FY2006 · GM · contact PI
UNC Plaining Grant for Clinical and Translation Science Award$219,000
P20 · FY2006 · RR · contact PI
UNC PLAINING GRANT FOR CLINICAL AND TRANSLATION SCIENCE AWARD$219,000
P20 · FY2006 · RR · contact PI
PERMEABILITY AMP; METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$10,903
M01 · FY2006 · RR · contact PI
NEUROPSYCHOLOGICAL DYSFUNCTION AND NEUROIMAGING ABNORMALITIES IN SCD$4,956
M01 · FY2006 · RR · contact PI
SAFETY AND EFFICACY OF HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL$1,734
M01 · FY2006 · RR · contact PI
OUTCOME MODIFYING GENES IN SICKLE CELL DISEASE$248
M01 · FY2006 · RR · contact PI
General Clinical ResearchCenter$5,238,648
M01 · FY2005 · RR
Multidisciplinary Clinical Research Career Develop(RMI)$1,540,002
K12 · FY2005 · RR
UNC-CH Mentored Clinical Research Scholar Program$1,173,329
K12 · FY2005 · RR
UNC BIRCWH Career Development Program$500,000
K12 · FY2005 · HD
Medical Scientist Training Program$439,958
T32 · FY2005 · GM
SAFETY AND EFFICACY OF HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL$4,084
M01 · FY2005 · RR
PERMEABILITY &METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$1,256
M01 · FY2005 · RR
OUTCOME MODIFYING GENES IN SICKLE CELL DISEASE$942
M01 · FY2005 · RR
THERAPY FOR AVASCULAR NECROSIS OF HIP/SICKLE$629
M01 · FY2005 · RR
General Clinical ResearchCenter$5,045,670
M01 · FY2004 · RR
UNC-CH Mentored Clinical Research Scholar Program$1,237,762
K12 · FY2004 · RR
UNC BIRCWH CAREER DEVELOPMENT PROGRAM$500,000
K12 · FY2004 · HD
Medical Scientist Training Program$439,958
T32 · FY2004 · GM
Integrilin in Patients with Sickle Cell Disease Who Are in Steady, Non-Crisis$11,038
M01 · FY2004 · RR
Permeability &Metabolism of RBC from Patients with Hemolytic Anemias$566
M01 · FY2004 · RR
Therapy for Avascular Necrosis of Hip/Sickle$566
M01 · FY2004 · RR
Safety and Efficacy of Hydroxyurea as a Prophylactic Therapy for Sickle Cell$283
M01 · FY2004 · RR
General Clinical ResearchCenter$4,487,543
M01 · FY2003 · RR
UNC-CH Mentored Clinical Research Scholar Program$1,007,819
K12 · FY2003 · RR
UNC BIRCWH CAREER DEVELOPMENT PROGRAM$500,000
K12 · FY2003 · HD
MEDICAL SCIENTIST TRAINING PROGRAM$289,046
T32 · FY2003 · GM
General Clinical Research Center Supplement$260,472
M01 · FY2003 · RR
GENERAL CLINICAL RESEARCH CENTER$4,165,655
M01 · FY2002 · RR
UNC-CH Mentored Clinical Research Scholar Program$521,856
K12 · FY2002 · RR
UNC BIRCWH CAREER DEVELOPMENT PROGRAM$500,000
K12 · FY2002 · HD
MEDICAL SCIENTIST TRAINING PROGRAM$242,780
T32 · FY2002 · GM
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$190,747
M01 · FY2002 · RR
PAIN THRESHOLD IN ADULTS WITH SICKLE CELL DISEASE$190,747
M01 · FY2002 · RR
PERMEABILITY AND METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$190,747
M01 · FY2002 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$190,747
M01 · FY2002 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$190,747
M01 · FY2002 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS WITH SICKLE CELL ANEMIA$190,747
M01 · FY2002 · RR
TREATMENT OF HAIRY CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE$190,747
M01 · FY2002 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$190,747
M01 · FY2002 · RR
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$190,747
M01 · FY2002 · RR
GENERAL CLINICAL RESEARCH CENTERS ANNUAL MEETING$21,281
U13 · FY2002 · RR
GENERAL CLINICAL RESEARCH CENTER$3,485,747
M01 · FY2001 · RR
UNC BIRCWH CAREER DEVELOPMENT PROGRAM$500,000
K12 · FY2001 · HD
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$294,555
M01 · FY2001 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$294,555
M01 · FY2001 · RR
PERMEABILITY AND METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$294,555
M01 · FY2001 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$294,555
M01 · FY2001 · RR
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$294,555
M01 · FY2001 · RR
PAIN THRESHOLD IN ADULTS WITH SICKLE CELL DISEASE$294,555
M01 · FY2001 · RR
TREATMENT OF HAIRY CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE$294,555
M01 · FY2001 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$294,555
M01 · FY2001 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS WITH SICKLE CELL ANEMIA$294,555
M01 · FY2001 · RR
PAIN THRESHOLD IN ADULTS WITH SICKLE CELL DISEASE$190,747
M01 · FY2001 · RR
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$190,747
M01 · FY2001 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$190,747
M01 · FY2001 · RR
TREATMENT OF HAIRY CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE$190,747
M01 · FY2001 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS WITH SICKLE CELL ANEMIA$190,747
M01 · FY2001 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$190,747
M01 · FY2001 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$190,747
M01 · FY2001 · RR
PERMEABILITY AND METABOLISM OF RBC FROM PATIENTS WITH HEMOLYTIC ANEMIAS$190,747
M01 · FY2001 · RR
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$190,747
M01 · FY2001 · RR
MEDICAL SCIENTIST TRAINING PROGRAM$178,488
T32 · FY2001 · GM
GENERAL CLINICAL RESEARCH CENTERS ANNUAL MEETING$166,628
U13 · FY2001 · RR
GCRC-CAP-DAVID WOHL, M.D. (ADDITIONAL TIME)$52,264
M01 · FY2001 · RR
RENOVATION OF GLAXO BUILDING$852,265
C06 · FY2000 · RR
UNC BIRCWH CAREER DEVELOPMENT PROGRAM$500,000
K12 · FY2000 · HD
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$294,555
M01 · FY2000 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$294,555
M01 · FY2000 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$294,555
M01 · FY2000 · RR
MEDICAL SCIENTIST TRAINING PROGRAM$122,891
T32 · FY2000 · GM
GENERAL CLINICAL RESEARCH CENTERS ANNUAL MEETING$120,223
U13 · FY2000 · RR
INHALED NITRIC OXIDE FOR TREATMENT OF SICKLE CELL CRISIS$241
M01 · FY2000 · RR
CLOTRIMAZOLE WITH HYDROXYUREA IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
CLOTRIMAZOLE WITH HYDROXYUREA IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
CLOTRIMAZOLE WITH HYDROXYUREA IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$0
M01 · FY2000 · RR
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$0
M01 · FY2000 · RR
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$0
M01 · FY2000 · RR
DECOMPRESSION CORING VS CONSERVATIVE THERAPY FOR AVASCULAR NECROSIS O$0
M01 · FY2000 · RR
FLOCOR IN SICKLE CELL DISEASE WITH ACUTE VASO-OCCLUSIVE CRISIS$0
M01 · FY2000 · RR
FLOCOR IN SICKLE CELL DISEASE WITH ACUTE VASO-OCCLUSIVE CRISIS$0
M01 · FY2000 · RR
FLOCOR IN SICKLE CELL DISEASE WITH ACUTE VASO-OCCLUSIVE CRISIS$0
M01 · FY2000 · RR
TREATMENT OF HAIRY CELL LEUKEMIA W/ 2-CHLORODEOXYADENOSINE$0
M01 · FY2000 · RR
TREATMENT OF HAIRY CELL LEUKEMIA W/ 2-CHLORODEOXYADENOSINE$0
M01 · FY2000 · RR
TREATMENT OF HAIRY CELL LEUKEMIA W/ 2-CHLORODEOXYADENOSINE$0
M01 · FY2000 · RR
TREATMENT OF HAIRY CELL LEUKEMIA W/ 2-CHLORODEOXYADENOSINE$0
M01 · FY2000 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS W/ SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS W/ SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS W/ SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA FOR TREATMENT OF RECURRENT LEG ULCERS IN PTS W/ SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
HYDROXYUREA AS A PROPHYLACTIC THERAPY FOR SICKLE CELL ANEMIA$0
M01 · FY2000 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$0
M01 · FY2000 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$0
M01 · FY2000 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$0
M01 · FY2000 · RR
TREATMENT OF SICKLE CELL ANEMIA WITH HYDROXYUREA$0
M01 · FY2000 · RR
PERMEABILITY &METABOLISM OF RBC FROM PTS W/ HEMOLYTIC ANEMIAS$0
M01 · FY2000 · RR
PERMEABILITY &METABOLISM OF RBC FROM PTS W/ HEMOLYTIC ANEMIAS$0
M01 · FY2000 · RR
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
PAIN THRESHOLD IN ADULTS WITH SICKLE CELL DISEASE$0
M01 · FY2000 · RR
PERMEABILITY &METABOLISM OF RBC FROM PTS W/ HEMOLYTIC ANEMIAS$0
M01 · FY2000 · RR
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
PERMEABILITY &METABOLISM OF RBC FROM PTS W/ HEMOLYTIC ANEMIAS$0
M01 · FY2000 · RR
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
FLOCOR IN SICKLE CELL DISEASE WITH ACUTE VASO-OCCLUSIVE CRISIS$0
M01 · FY2000 · RR
ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR
CLOTRIMAZOLE WITH HYDROXYUREA IN SICKLE CELL DISEASE$0
M01 · FY2000 · RR